Ketones buy time for a failing heart but are just more fuel for a healthy one, says study
In 2015, researchers began noticing that a drug used to treat Type 2 diabetes, empagliflozin, came with the added benefit of decreasing hospitalization for heart failure and death from cardiovascular causes in those patients.
Oct 7, 2020
0
3